The EASD in Munich was notable for two Endobarrier related events. There was a presentation of data on well over 200 patients from the German Endobarrier registry which confirmed the efficacy of this novel treatment for type 2 diabetes and obesity.
NHS England has announced in its planning guidance for 2017-2019 an investment of £40 million per year for at least two years for diabetes. Details of how to bid for a share of this have yet to be announced, but the topics will reflect the NHSE priorities - improving uptake of structured education; improving access to specialist inpatient support and to a multi-disciplinary foot team for people with diabetic foot disease; and improving the achievement of the NICE recommended treatment targets whilst driving down variation between CCGs. Get drafting your proposals and get talking
http://buff.ly/2d0OTaB: On 12 June 2016 the 1-year results of the REVISE-Diabesity research study of Endobarrier treatment, including an assessment of the impact on 10-year cardiovascular risk, were presented at the 76th Scientific Sessions of the American Diabetes Association in New Orleans, USA, by the study’s Chief Investigator, Dr Bob Ryder. The headline results were that in the Endobarrier with l
The annual campaign to raise awareness of hypoglycaemia in the UK by educating healthcare professionals will take place between Monday, October 3, and Sunday, October 9.
The theme for this year is optimum control and the autumn awareness drive is calling for the best possible control of diabetes to avoid hypos.
As well as the customary secondary care focus, primary care professionals are also invited to register as part of a wider campaign for 2016.
Diabetes UK launched the 2016 State of the Nation report at the House of Commons on 13th July amid the Westminster bustle of David Cameron’s final Prime Minister’s questions (PMQ) and the fevered anticipation of who would be in Mrs May’s cabinet. The event was well supported with several MPs arriving after PMQ. The Rt Hon Jeremy Hunt MP (Secretary of State for Health) described strategies being implemented to preven
See: https://youtu.be/y1zm0Scq6YM. On 3 June 2016 the first patient in the ABCD Endobarrier in obstructive sleep apnoea (End-OSA study) was started on her Endobarrier treatment. The BBC interviewed the patient and filmed the procedure for this news item. The aim is to see
Click HERE to read the report from ABCD (Diabetes Care) Ltd committee chairman, Dr Rob Gregory
Click HERE to read the report from ABCD (Diabetes Care) Ltd committee chairman, Dr Rob Gregory
The Association continues to champion the cause of best care for people with type 1 diabetes. Work is ongoing to ensure that the distinct needs of this group are recognised within the modern commissioning landscape.
A drive to improve the care of people with diabetes admitted to Leicester’s hospitals has been launched.
Two initiatives have been set up to help doctors at the University Hospital of Leicester NHS Trust improve their understanding and knowledge about diabetes management and insulin safety in hospital.
